DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
Transactions / Biological Specialty Corporation
Thompson Street Capital Partners Portfolio Company BioIVT Acquires Biological Specialty Corporation
Add-on acquisitionclosedadd-onannounced Nov 5, 2018closed Nov 5, 2018Fact
What happened
- Platform
- BioIVTadd-on basis: Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company BioIVT, a leading global provider of research models and value-added research services for drug discovery and development, has acquired Colmar, Pennsylvania-based Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community.
- Control
- Control
- Share acquired
- unknown
- Industry
- industrials / components
- Target location
- PA, US
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
3 named
Buy side
- “Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company BioIVT, a leading global provider of research models and value-added research services for drug discovery and development, has acquired Colmar, Pennsylvania-based Biological ”
- “Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company BioIVT, a leading global provider of research models and value-added research services for drug discovery and development, has acquired Colmar, Pennsylvania-based Biological ”
Side not stated
- “Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company BioIVT, a leading global provider of research models and value-added research services for drug discovery and development, has acquired Colmar, Pennsylvania-based Biological ”
Evidence
“Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company BioIVT, a leading global provider of research models and value-added research services for drug discovery and development, has acquired Colmar, Pennsylvania-based Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026